000538 Yunnan Baiyao GroupWatchlist
About Yunnan Baiyao Group Company
The company was founded in 1902, integrates brands, products and company names, and is recognized by the industry as the most innovative representative of time-honored brands in China. With a brand value of more than 30 billion yuan, it ranked 4th among pharmaceutical companies in the country, ranked 1st in traditional Chinese medicine, was selected as the top 25 global pharmaceutical brands in value in July 2021, and ranked as the strongest pharmaceutical brand in China, and ranked 34th among global pharmaceutical companies in 2021. In 1970, Premier Zhou Enlai ordered the establishment of the Yunnan Baiyao Special Factory. It was listed as the first stock in Yunnan in 1993, fully modernized enterprise restructuring was carried out in 1999, and mixed reform and overall listing were completed from 2016 to 2019, laying a solid institutional foundation for the company to create another 100 years of glory. The company continues to use the division structure as the core basis for production and operation. At the product level, on the basis of stabilizing traditional advantageous stocks such as Yunnan Baiyao Central Products (Yunnan Baiyao series core products), general medicine, toothpaste, etc., the company actively explores incremental businesses such as 37 series of oral liquids, household medical devices, personalized skincare product groups, scalp health management product groups, health care products, and new resource foods. The Pharmaceutical Division mainly focuses on Yunnan Baiyao's main series of core products for hemostasis, pain relief, swelling and stasis relief (Yunnan Baiyao aerosol, Yunnan Baiyao cream, Yunnan Baiyao band-aid, etc.), and also covers other brands of traditional Chinese medicine in the fields of blood, flu and cold, cardiovascular, gynecology, and children. The Health Products Division, with the toothpaste category as the core of its business, is developing new categories of oral care, health care and anti-peeling care. The Traditional Chinese Medicine Resources Division focuses on medicinal plant resources characteristic of Yunnan Province, while ensuring the high-quality, efficient, and low-cost supply of the Group's traditional Chinese medicine raw materials, and creates B-end products including the 37 series, branded medicinal herbs, natural plant extracts, etc., as well as C-end products including traditional Chinese medicine tablets and health food families. Company honors: Yunnan Baiyao ranked 55th in the “2017 China Corporate Social Responsibility 500 Excellent” list, on March 26, BrandZ released the 2018 Top 100 Most Valuable Chinese Brands, Yunnan Baiyao ranked 28th, ranked 28th in brand value in the healthcare sector for 7 consecutive years, and on April 8, Yunnan Baiyao ranked 5th in the “2017 Top 100 Listed Companies Most Respected by Investors” list of the China Association of Listed Companies, etc.